US price hike probe: Sun Pharma, DRL, Cadila tank 2-5%

This probed seems to be triggered by National Community Pharmacists Association (NCPA) 2013 survey of drug prices. In 2014, the NCPA had written to the US Senate seeking investigation into large upswing in acquisition prices of generic medicines.

October 08, 2014 / 06:22 PM IST

live

bselive
nselive

Volume

Todays L/H

Tags: #Buzzing Stocks #Cadila Healthcare #Dr Reddys Laboratories #NCPA #Sun Pharmaceutical Industries #US Congress

first published: Oct 8, 2014 11:46 am

Discover the latest business news, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347

Expert Trading Guidance

US price hike probe: Sun Pharma, DRL, Cadila tank 2-5%

This probed seems to be triggered by National Community Pharmacists Association (NCPA) 2013 survey of drug prices. In 2014, the NCPA had written to the US Senate seeking investigation into large upswing in acquisition prices of generic medicines.